BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic
disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) …

Although great progress has been made in the diagnostic and treatment options for
dyslipidemias, unawareness, underdiagnosis and undertreatment of these disorders remain …

Historically, newborn screening for lipid disorders was not done for many reasons, but new
research has developed testing methods that may successfully identify common and rare …

Aims The availability of novel lipid-lowering therapies (LLTs) has remarkably changed the
clinical management of homozygous familial hypercholesterolaemia (HoFH). The impact of …

Background and aims Homozygous familial hypercholesterolaemia (FH) causes severe
cardiovascular disease from childhood. Conventional drug therapy is usually ineffective; …

Familial hypercholesterolaemia is a common, autosomal, semidominant genetic disorder
that is characterised by increased LDL cholesterol (LDL-C) from birth and, if left untreated …

Homozygous familial hypercholesterolemia (HoFH) is an underdiagnosed and undertreated
ultra-rare disease. We utilized claims data from the Komodo Healthcare Map database to …

Homozygous familial hypercholesterolemia (HoFH) is a rare and serious genetic condition
characterized by premature cardiovascular disease due to severely elevated low‐density …

To the Editor The Agency for Healthcare Research and Quality describes the USPSTF as
follows:“The USPSTF works to improve the health of people nationwide by making …

Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that
affects approximately one in 300,000 people. The disorder is characterized by extremely …